(ustekinumab)
This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.
STELARA® (ustekinumab)
Patient Medical Information
Do STELARA Single-Dose Vials Contain Latex?
Last Updated: 12/06/2024
summary
STELARA single-dose vial (subcutaneous injection: 45 mg/0.5 mL; intravenous injection: 130 mg/26 mL [5 mg/mL]) materials do not contain latex as an ingredient; however, we cannot guarantee that the materials do not come in contact with latex during the manufacturing or packaging process (e.g. latex gloves).1
This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.
Please refer to the attached full PRESCRIBING INFORMATION and the MEDICATION GUIDE for STELARA.2
References
| 1 | Data on File. Ustekinumab. Patient Safety and Compliance Information. Janssen Research and Development, LLC; 2022. |
| 2 |